BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 2996362)

  • 1. Calcium, cAMP, and dopamine affect single mammotrophs assayed by hemolytic plaques.
    Anderson JM; Keefer DA; Koritnik DD; Yasumoto T; Cronin MJ
    Am J Physiol; 1985 Oct; 249(4 Pt 1):E337-44. PubMed ID: 2996362
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dopamine inhibits maitotoxin-stimulated pituitary 45Ca2+ efflux and prolactin release.
    Login IS; Judd AM; MacLeod RM
    Am J Physiol; 1986 Jun; 250(6 Pt 1):E731-5. PubMed ID: 3717333
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dopamine decreases 7315a tumor cell prolactin release induced by calcium mobilization.
    Judd AM; Koike K; Schettini G; Login IS; Hewlett EL; Yasumoto T; MacLeod RM
    Endocrinology; 1985 Sep; 117(3):1215-21. PubMed ID: 3926467
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dopaminergic inhibition of anterior pituitary adenylate cyclase activity and prolactin release: the effects of perturbing calcium on catalytic adenylate cyclase activity.
    Schettini G; Hewlett EL; Cronin MJ; Koike K; Yasumoto T; MacLeod RM
    Neuroendocrinology; 1986; 44(1):1-7. PubMed ID: 3024052
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interleukin-1-beta modulation of prolactin secretion from rat anterior pituitary cells: involvement of adenylate cyclase activity and calcium mobilization.
    Schettini G; Florio T; Meucci O; Landolfi E; Grimaldi M; Lombardi G; Scala G; Leong D
    Endocrinology; 1990 Mar; 126(3):1435-41. PubMed ID: 2407518
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Calcitonin decreases thyrotropin-releasing hormone-stimulated prolactin release through a mechanism that involves inhibition of inositol phosphate production.
    Judd AM; Kubota T; Kuan SI; Jarvis WD; Spangelo BL; Macleod RM
    Endocrinology; 1990 Jul; 127(1):191-9. PubMed ID: 2163310
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Maitotoxin stimulates hormonal release and calcium flux in rat anterior pituitary cells in vitro.
    Schettini G; Koike K; Login IS; Judd AM; Cronin MJ; Yasumoto T; MacLeod RM
    Am J Physiol; 1984 Oct; 247(4 Pt 1):E520-5. PubMed ID: 6496670
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dopamine receptor and adrenoceptor agonists inhibit prolactin release from MMQ cells.
    Judd AM; MacLeod RM
    Eur J Pharmacol; 1991 Mar; 195(1):101-6. PubMed ID: 1676676
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dopamine inhibits calcium flux in the 7315a prolactin-secreting pituitary tumour.
    Login IS; Judd AM; Macleod RM
    Cell Calcium; 1988 Feb; 9(1):27-31. PubMed ID: 3359479
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A possible role of arachidonate metabolism in the mechanism of prolactin release.
    Judd AM; Koike K; MacLeod RM
    Am J Physiol; 1986 Mar; 250(3 Pt 1):E288-95. PubMed ID: 2420203
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of the MMQ cell, a prolactin-secreting clonal cell line that is responsive to dopamine.
    Judd AM; Login IS; Kovacs K; Ross PC; Spangelo BL; Jarvis WD; MacLeod RM
    Endocrinology; 1988 Nov; 123(5):2341-50. PubMed ID: 2844508
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Maitotoxin increases inositol phosphates in rat anterior pituitary cells.
    Sortino MA; Delahunty TM; Yasumoto T; Cronin MJ
    J Mol Endocrinol; 1991 Feb; 6(1):95-9. PubMed ID: 1849719
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reserpine is a calcium channel antagonist in normal and GH3 rat pituitary cells.
    Login IS; Judd AM; Cronin MJ; Yasumoto T; MacLeod RM
    Am J Physiol; 1985 Jan; 248(1 Pt 1):E15-9. PubMed ID: 2578255
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Subpopulations of lactotropes detected with the reverse hemolytic plaque assay show differential responsiveness to dopamine.
    Luque EH; Munoz de Toro M; Smith PF; Neill JD
    Endocrinology; 1986 May; 118(5):2120-4. PubMed ID: 3084212
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stimulation of the adenosine 3',5'-monophosphate and the Ca2+ messenger systems together reverse dopaminergic inhibition of prolactin release.
    Delbeke D; Dannies PS
    Endocrinology; 1985 Aug; 117(2):439-46. PubMed ID: 2990850
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effects of maitotoxin on 45Ca2+ flux and hormone release in GH3 rat pituitary cells.
    Login IS; Judd AM; Cronin MJ; Koike K; Schettini G; Yasumoto T; MacLeod RM
    Endocrinology; 1985 Feb; 116(2):622-7. PubMed ID: 2578383
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Calcium mobilization potentiates prolactin release induced by protein kinase C activators.
    Koike K; Judd AM; Yasumoto T; MacLeod RM
    Mol Cell Endocrinol; 1985 May; 40(2-3):137-43. PubMed ID: 3159606
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Maitotoxin stimulates steroid and peptide hormone secretion by swine luteal tissue.
    Veldhuis JD; Yoshida K; DuBois W; Fields MJ
    Am J Physiol; 1987 Jan; 252(1 Pt 1):E8-12. PubMed ID: 3028150
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acute effect of basic fibroblast growth factor on secretion of prolactin as assessed by the reverse hemolytic plaque assay.
    Larson GH; Koos RD; Sortino MA; Wise PM
    Endocrinology; 1990 Feb; 126(2):927-32. PubMed ID: 2105207
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adenosine 3',5'-monophosphate (cAMP) and calcium-calmodulin interrelation in the control of prolactin secretion: evidence for dopamine inhibition of cAMP accumulation and prolactin release after calcium mobilization.
    Schettini G; Cronin MJ; MacLeod RM
    Endocrinology; 1983 May; 112(5):1801-7. PubMed ID: 6299710
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.